Skip to main content
Erschienen in: Critical Care 1/2020

Open Access 01.12.2020 | Letter

Percutaneous right ventricular assist device, rapid employment in right ventricular failure during septic shock

verfasst von: Ignazio Condello

Erschienen in: Critical Care | Ausgabe 1/2020

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Right ventricular (RV) failure, defined by critical care echocardiography Right Ventricular dilatation) and a surrogate of venous congestion (Central Venous Pressure ≥ 8 mmHg), was frequently observed in septic shock patients and negatively associated with response to a fluid challenge despite significant pulse pressure variation (PPV) [1]. Right Heart Failure with invasive ventricular device is associated with significant morbidity and mortality. A new generation of percutaneous right ventricular assist devices (RVADs) may mitigate the need for invasive surgical RVAD implantation [2]. The Protek Duo (TPD) temporary RVAD, capable of providing up to 4.5 L/min [3], is a dual-lumen cannula inserted via the right internal jugular vein, with its proximal inflow lumen positioned in the right atrium and distal lumen positioned in the main pulmonary artery [4]. In this context, we read with interest the article: “Right ventricular failure in septic shock: characterization, incidence and impact on fluid responsiveness” by Vieillard-Baron A. and other authors. The article presents a multicenter care unit study about the incidence of RV failure on 282 patients with septic shock, its potential impact on the response to fluids, as well as tricuspid annular plane systolic excursion (TAPSE) values. Three groups of patients were compared according to RV size and CVP, a good surrogate of venous congestion. The study concluded that RV failure, defined by critical care echocardiography (RV dilatation) and a surrogate of venous congestion (CVP ≥ 8 mmHg), was frequently observed in septic shock patients and negatively associated with response to a fluid challenge despite significant PPV [1]. In this context, we propose for the ventilated septic shock patients with RV failure defined using critical care echocardiography (RV/LV end-diastolic area EDA ≥ 0.6) and a surrogate of venous congestion (CVP ≥ 8 mmHg), observed (42%) with a negative effect on the response to a fluid challenge, the rapid implantation of percutaneous right ventricular assist, with Protek Duo (TPD) device. The TPD weapon in association with or without membrane oxygenator (Fig. 1), with or without cytokine filters, could support: the right ventricular function hemodynamics, the ventricular recovery function, the pulmonary function and gas exchange, the barotrauma reduction, the fluid challenge response and containment of cytokine release syndrome. However, this approach may have a high impact in terms of healthcare costs, but we hypothesize it can significantly improve the outcome in the patients with right ventricular failure and septic shock patients, future studies should validate this technique and potential benefits.

Acknowledgements

Not applicable.
Not applicable.
Not applicable.

Competing interests

The authors declare that there is no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Vieillard-Baron A, Prigent A, Repessé X, Goudelin M, Prat G, Evrard B, Charron C, Vignon P, Geri G. Right ventricular failure in septic shock: characterization, incidence and impact on fluid responsiveness. Crit Care. 2020;24(1):630.CrossRefPubMedPubMedCentral Vieillard-Baron A, Prigent A, Repessé X, Goudelin M, Prat G, Evrard B, Charron C, Vignon P, Geri G. Right ventricular failure in septic shock: characterization, incidence and impact on fluid responsiveness. Crit Care. 2020;24(1):630.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Salna M, Garan AR, Kirtane AJ, Karmpaliotis D, Green P, Takayama H, Sanchez J, Kurlansky P, Yuzefpolskaya M, Colombo PC, Naka Y, Takeda K. Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2020;30(4):499–506.CrossRefPubMed Salna M, Garan AR, Kirtane AJ, Karmpaliotis D, Green P, Takayama H, Sanchez J, Kurlansky P, Yuzefpolskaya M, Colombo PC, Naka Y, Takeda K. Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2020;30(4):499–506.CrossRefPubMed
3.
Zurück zum Zitat Ravichandran AK, Baran DA, Stelling K, Cowger JA, Salerno CT. Outcomes with the tandem Protek duo dual-lumen percutaneous right ventricular assist device. ASAIO J. 2018;64(4):570–2.CrossRefPubMed Ravichandran AK, Baran DA, Stelling K, Cowger JA, Salerno CT. Outcomes with the tandem Protek duo dual-lumen percutaneous right ventricular assist device. ASAIO J. 2018;64(4):570–2.CrossRefPubMed
4.
Zurück zum Zitat Patel NJ, Verma DR, Gopalan R, Heuser RR, Pershad A. Percutaneous biventricular mechanical circulatory support with impella CP and protek duo plus tandem heart. J Invasive Cardiol. 2019;31(2):E46.PubMed Patel NJ, Verma DR, Gopalan R, Heuser RR, Pershad A. Percutaneous biventricular mechanical circulatory support with impella CP and protek duo plus tandem heart. J Invasive Cardiol. 2019;31(2):E46.PubMed
Metadaten
Titel
Percutaneous right ventricular assist device, rapid employment in right ventricular failure during septic shock
verfasst von
Ignazio Condello
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 1/2020
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-03413-4

Weitere Artikel der Ausgabe 1/2020

Critical Care 1/2020 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.